
Sign up to save your podcasts
Or


In the latest installment of Ropes & Gray’s Alumni @ RopesTalk podcast, life sciences partner Amanda Austin, who’s also a member of the firm’s alumni committee, interviews alum and friend Heidy (Abreu) King-Jones, former chief legal officer at Provention Bio. Heidy was an associate at Ropes & Gray from 2008 – 2013, after which she took in-house roles at Sarepta Therapeutics, Axcella and Provention Bio. As a self-described “student of law, student of biotech and student of life,” Heidy talks broadly about her career, with detours into the experience of working at Provention Bio during its acquisition by Sanofi. She shares what she learned at Ropes & Gray, including an important lesson about client service. For anyone thinking about next steps in their career, Heidy also offers great advice focused on where you find professional joy versus professional drain. This interview was recorded on May 25, shortly before Heidy’s departure from Provention Bio, which was acquired by Sanofi in April.
By Ropes & Gray LLP4.5
1515 ratings
In the latest installment of Ropes & Gray’s Alumni @ RopesTalk podcast, life sciences partner Amanda Austin, who’s also a member of the firm’s alumni committee, interviews alum and friend Heidy (Abreu) King-Jones, former chief legal officer at Provention Bio. Heidy was an associate at Ropes & Gray from 2008 – 2013, after which she took in-house roles at Sarepta Therapeutics, Axcella and Provention Bio. As a self-described “student of law, student of biotech and student of life,” Heidy talks broadly about her career, with detours into the experience of working at Provention Bio during its acquisition by Sanofi. She shares what she learned at Ropes & Gray, including an important lesson about client service. For anyone thinking about next steps in their career, Heidy also offers great advice focused on where you find professional joy versus professional drain. This interview was recorded on May 25, shortly before Heidy’s departure from Provention Bio, which was acquired by Sanofi in April.

30,839 Listeners

4,222 Listeners

1,999 Listeners

488 Listeners

178 Listeners

683 Listeners

57,066 Listeners

32,374 Listeners

835 Listeners

5,655 Listeners

404 Listeners

679 Listeners

13,642 Listeners